A statement of reaffirmation for this policy was published on May 1, 2009.
This policy is a revision of the policy posted on June 1, 1998.

POLICY STATEMENT

PEDIATRICS Vol. 116 No. 4 October 2005, pp. 1036-1046 (doi:10.1542/peds.2005-1947)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

POLICY STATEMENT

Lead Exposure in Children: Prevention, Detection, and Management

Committee on Environmental Health

Fatal lead encephalopathy has disappeared and blood lead concentrations have decreased in US children, but approximately 25% still live in housing with deteriorated lead-based paint and are at risk of lead exposure with resulting cognitive impairment and other sequelae. Evidence continues to accrue that commonly encountered blood lead concentrations, even those less than 10 µg/dL, may impair cognition, and there is no threshold yet identified for this effect. Most US children are at sufficient risk that they should have their blood lead concentration measured at least once. There is now evidence-based guidance available for managing children with increased lead exposure. Housing stabilization and repair can interrupt exposure in most cases. The focus in childhood lead-poisoning policy, however, should shift from case identification and management to primary prevention, with a goal of safe housing for all children.

Key Words: child • lead • environmental exposure • chelation therapy • succimer • cognition • clinical trials • housing • prevention • behavior

Abbreviations: CDC, Centers for Disease Control and Prevention • AAP, American Academy of Pediatrics • EPA, Environmental Protection Agency • CNS, central nervous system • EP, erythrocyte protoporphyrin • EDTA, ethylenediaminetetraacetic acid • TLC, Treatment of Lead-Exposed Children • HUD, Department of Housing and Urban Development


Statement of reaffirmation:

AAP Publications Retired and Reaffirmed
Pediatrics 2009 123: 1421-1422. [Extract] [Full Text] [PDF]

The following policy statement has been revised:

Screening for Elevated Blood Lead Levels
Committee on Environmental Health
Pediatrics 1998 101: 1072-1078. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 PediatricsHome page
Committee on Environmental Health
The Built Environment: Designing Communities to Promote Physical Activity in Children
Pediatrics, June 1, 2009; 123(6): 1591 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. L. Jones, D. M. Homa, P. A. Meyer, D. J. Brody, K. L. Caldwell, J. L. Pirkle, and M. J. Brown
Trends in Blood Lead Levels and Blood Lead Testing Among US Children Aged 1 to 5 Years, 1988-2004
Pediatrics, March 1, 2009; 123(3): e376 - e385.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
R. Rabin
The Lead Industry and Lead Water Pipes "A MODEST CAMPAIGN"
Am J Public Health, September 1, 2008; 98(9): 1584 - 1592.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
H. J. Binns, C. Campbell, M. J. Brown, and for the Advisory Committee on Childhood Lead Poiso
Interpreting and Managing Blood Lead Levels of Less Than 10 {micro}g/dL in Children and Reducing Childhood Exposure to Lead: Recommendations of the Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention
Pediatrics, November 1, 2007; 120(5): e1285 - e1298.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
A. C. Soeiro, T. S. Gouvea, and E. G. Moreira
Behavioral effects induced by subchronic exposure to Pb and their reversion are concentration and gender dependent
Human and Experimental Toxicology, September 1, 2007; 26(9): 733 - 739.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
R. M. Bossarte, M. J. Brown, and R. L. Jones
Blood Lead Misclassification Due to Defective LeadCare(R) Blood Lead Testing Equipment
Clin. Chem., May 1, 2007; 53(5): 994 - 995.
[Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
R. C. Gracia and W. R. Snodgrass
Lead toxicity and chelation therapy
Am. J. Health Syst. Pharm., January 1, 2007; 64(1): 45 - 53.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
US Preventive Services Task Force
Screening for Elevated Blood Lead Levels in Children and Pregnant Women
Pediatrics, December 1, 2006; 118(6): 2514 - 2518.
[Full Text] [PDF]

Home page
 PediatricsHome page
G. Rischitelli, P. Nygren, C. Bougatsos, M. Freeman, and M. Helfand
Screening for Elevated Lead Levels in Childhood and Pregnancy: An Updated Summary of Evidence for the US Preventive Services Task Force
Pediatrics, December 1, 2006; 118(6): e1867 - e1895.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
L. Gruen and L. Grabel
Concise Review: Scientific and Ethical Roadblocks to Human Embryonic Stem Cell Therapy
Stem Cells, October 1, 2006; 24(10): 2162 - 2169.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. McLaine, M. J. Brown, and P. Simon
Home Visiting and Childhood Lead Poisoning Prevention: In Reply
Pediatrics, June 1, 2006; 117(6): 2329 - 2330.
[Full Text] [PDF]

Home page
 PediatricsHome page
A. D. Woolf
Home visiting and childhood lead poisoning prevention.
Pediatrics, June 1, 2006; 117(6): 2328 - 2329.
[Full Text] [PDF]

Home page
 JAMAHome page
R. Morley
The Cost of Being Poor: Poverty, Lead Poisoning, and Policy Implementation
JAMA, April 12, 2006; 295(14): 1711 - 1712.
[Full Text] [PDF]